ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Pure Medical Treatment of Early-Stage NSCLC: Is it Foreseeable?
Thursday, June 29, 2023
As a part of Session 12 of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, Nicolas Girard of Paris, France, presented on the possibility of pure medical treatment of early-stage NSCLC.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
